Today: 21 May 2026

Broadcom (AVGO) stock slips at the open as Cisco targets its AI networking turf

Broadcom (AVGO) stock slips at the open as Cisco targets its AI networking turf

Broadcom shares slipped 0.25% to $343.09 early Tuesday after a 3.31% jump in the previous session. Cisco launched its Silicon One G300 switch chip for AI data centers, entering a market where Broadcom’s Tomahawk chips compete. Investors await U.S. payrolls data Wednesday, CPI Friday, and Broadcom’s earnings on March 4. Broadcom stock remains 17% below its 52-week high.
Tesla stock jumps early as Musk’s xAI chip funding puts TSLA back in play

Tesla stock jumps early as Musk’s xAI chip funding puts TSLA back in play

Tesla shares rose 1.7% to $424.36 in early trading Tuesday, extending Monday’s gains. The move followed reports that Apollo Global Management is close to a $3.4 billion loan deal for Nvidia chips to be leased to Elon Musk’s xAI. Investors are watching for U.S. jobs data this week, which could affect rate expectations and high-growth stocks.
Nvidia (NVDA) stock price ticks up as chip-tariff carve-out report lands, with Feb. 25 earnings next

Nvidia (NVDA) stock price ticks up as chip-tariff carve-out report lands, with Feb. 25 earnings next

Nvidia shares rose 0.9% to $191.75 in early Tuesday trading after reports of a possible U.S. tariff exemption for major AI data-center buyers. TSMC, Nvidia’s main supplier, said January revenue jumped 19.8% from December. The White House has not finalized the tariff carve-out, according to officials. Investors await Nvidia’s earnings on Feb. 25 for further direction.
Micron stock slides on Nvidia HBM4 fears as Samsung, SK hynix loom

Micron stock slides on Nvidia HBM4 fears as Samsung, SK hynix loom

Micron shares fell 2.9% to $383.50 early Tuesday after reports suggested Samsung and SK hynix may secure most early HBM4 supply for Nvidia’s next AI platform. BusinessKorea cited sources saying Micron may be excluded from Nvidia’s initial supplier list due to performance issues. Investors await Micron’s Feb. 11 conference appearance for updates on HBM4 qualification. Nvidia and AMD shares rose in early trading.
BigBear.ai stock steadies premarket as investors brace for Feb. 18 vote on share increase

BigBear.ai stock steadies premarket as investors brace for Feb. 18 vote on share increase

BigBear.ai shares held at $4.87 in premarket trading Tuesday after a 3.2% gain and heavy volume the prior session. Shareholders will vote Feb. 18 on doubling authorized common shares to 1 billion. The company recently announced a partnership with AD Ports Group and acquired CargoSeer technologies. Online voting for the share proposal closes Feb. 17 at 11:59 p.m. ET.
10 February 2026
Amazon stock slips premarket as report flags AWS plan for an AI content marketplace

Amazon stock slips premarket as report flags AWS plan for an AI content marketplace

Amazon shares fell 0.8% to $208.72 in premarket trading Tuesday after a report said AWS is planning a marketplace for publishers to sell content to AI firms. The Information said AWS shared slides referencing the marketplace ahead of its conference. Amazon declined to comment on specifics. Investors are watching for details on licensing terms and costs as AI-related spending rises.
MARA stock slips in premarket after Morgan Stanley starts coverage with an underweight call

MARA stock slips in premarket after Morgan Stanley starts coverage with an underweight call

MARA Holdings shares fell 2.3% to $8.06 premarket after Morgan Stanley initiated coverage with an underweight rating and $8 target. The bank cited MARA’s continued exposure to bitcoin price swings over data center leasing. TeraWulf and Cipher Mining surged in early trading, while Riot Platforms rose 3.6%. MARA has not announced its next earnings date, though estimates point to Feb. 25.
Vale stock price slips premarket after courts reject 2.846 bln-real asset-freeze bids

Vale stock price slips premarket after courts reject 2.846 bln-real asset-freeze bids

Vale’s U.S.-listed shares fell 0.8% to $16.66 premarket after Brazilian courts rejected most asset-freeze requests tied to January overflows at its sites. One 200 million reais freeze request remains pending, while operations at Fábrica and Viga units stay suspended. Investors await Vale’s quarterly results due Feb. 12. Iron ore futures in Singapore edged up 0.5% to $100.4 a ton.
10 February 2026
Kenvue stock price today: KVUE holds near $18 as Feb. 17 results and Kimberly-Clark deal hang over the week

Kenvue stock price today: KVUE holds near $18 as Feb. 17 results and Kimberly-Clark deal hang over the week

Kenvue shares traded flat in premarket Tuesday, holding at $18.18 after Monday’s close. The company will report fourth-quarter and full-year results on Feb. 17 with no earnings call, citing its pending merger with Kimberly-Clark. Shareholders of record Feb. 11 will receive a $0.2075 dividend. The merger, approved Jan. 29, is expected to close in the second half of 2026, pending regulatory review.
10 February 2026
Snap stock jumps in premarket after analyst upgrade as SNAP tries to rebound

Snap stock jumps in premarket after analyst upgrade as SNAP tries to rebound

Snap Inc. shares rose 3.7% to $5.38 in premarket trading after Arete Research upgraded the stock to buy and trimmed its price target to $7.30. The move follows a volatile stretch after Snap’s quarterly results and a new $500 million buyback plan. Snap ended Monday at $5.19, near the bottom of its 52-week range. Analyst sentiment remains cautious, with most ratings at “Hold.”
10 February 2026
Plug Power stock (PLUG) steadies before the bell as make-or-break share vote nears

Plug Power stock (PLUG) steadies before the bell as make-or-break share vote nears

Plug Power shares held at $2.10 in premarket trading Tuesday as investors awaited a Feb. 17 shareholder vote on expanding authorized shares to 3 billion. The company failed to secure enough votes last week, with only 39.63% backing Proposal 1. CEO Andy Marsh warned a reverse stock split could follow if the measure fails. Plug shares remain down 54% from their 52-week high.
Hims & Hers stock drops again premarket as $49 weight-loss pill reversal fuels legal, FDA scrutiny

Hims & Hers stock drops again premarket as $49 weight-loss pill reversal fuels legal, FDA scrutiny

Hims & Hers Health shares dropped 4.2% to $18.52 premarket Tuesday after plunging 16% Monday. The company halted its compounded semaglutide pill following warnings from U.S. regulators and a new patent lawsuit by Novo Nordisk. The FDA signaled plans to restrict non-approved GLP-1 drugs and may take legal action. The Department of Health and Human Services referred Hims to the Justice Department.
Bitcoin Price Clings to $70,000 After Rout as Bernstein Sticks With $150,000 Call

Bitcoin Price Clings to $70,000 After Rout as Bernstein Sticks With $150,000 Call

Bitcoin hovered near $70,000 in New York trading Monday after rebounding from a low of $61,000 last week. Bernstein’s Gautam Chhugani called the sell-off a “crisis of confidence” and kept a $150,000 target. Traders monitored spot ETF flows and miner data for signs of stability. Bitcoin is down about 44% from its October 2025 high above $126,000.
Jumia stock drops premarket as Q4 revenue trails estimates; 2026 outlook, Algeria exit in focus

Jumia stock drops premarket as Q4 revenue trails estimates; 2026 outlook, Algeria exit in focus

Jumia shares dropped 3.75% to $11.81 in premarket trading after fourth-quarter revenue rose 34% to $61.4 million, missing estimates. The company forecast 2026 GMV growth of up to 32% and an adjusted EBITDA loss of $25–$30 million, and said it will exit Algeria in the first quarter. Operating loss narrowed to $10.6 million. Liquidity stood at $77.8 million at year-end.
Fiserv stock rises in premarket after earnings beat, but 2026 “transition year” looms

Fiserv stock rises in premarket after earnings beat, but 2026 “transition year” looms

Fiserv shares rose about 3% in premarket trading Tuesday after fourth-quarter adjusted earnings per share fell 21% to $1.99 but beat analyst estimates. The company forecast 2026 adjusted EPS of $8.00 to $8.30 and organic revenue growth of 1% to 3%. Shares last closed at $60.11, down 74% over the past year. Investors await more detail on growth plans at the 8 a.m. ET earnings call.

Stock Market Today

  • SpaceX IPO Filing Reveals Financials, Musk Could Become First Trillionaire
    May 20, 2026, 7:08 PM EDT. SpaceX filed for an initial public offering (IPO), disclosing its finances and board members for the first time. The company reported $18.7 billion in revenue for 2025, up 33% year-on-year, but posted a net loss of $4.9 billion, reversing a $791 million profit in 2024. First-quarter 2026 losses reached $4.3 billion on $4.7 billion revenue. The IPO, trading as SPCX, may become the largest ever, potentially boosting Elon Musk's wealth to trillionaire status. SpaceX aims to fund its ambitious plans including Starlink satellite network expansion, AI infrastructure, and establishing extraterrestrial colonies.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop